Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-013155

Chief Medical Officer acquired 79,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Waheed Nadia Chief Medical Officer 2025-02-11 Grant or award +79,000 220,666 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Waheed Nadia Chief Medical Officer 2025-02-11 Grant or award · Stock Option (Right to Buy) +237,000 237,000 D: show line 2 in the form
Loading xslF345X05/tm256513-3_4seq1.xml…